Sodium Phosphates Injection, Solution
Product Images NDC 68462-730

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Sodium Phosphates (NDC 68462-730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Logo)

FDA Label Image

Sodium-phosphates-carton-15ml (Sodium Phosphates Carton 15ml)

Sodium Phosphates Injection, USP 45 mM P/15 mL (3 mM P/mL), 60 mEq Na+/15 mL (4 mEq Na+/mL) in single-dose vials. The label shows 25 vials of 15 mL each, manufactured by Glenmark Pharmaceuticals Inc., USA. It includes usage caution for dilution and intravenous use, along with storage instructions and ingredients.*

FDA Label Image

Sodium-phosphates-carton-50ml (Sodium Phosphates Carton 50ml)

Sodium Phosphates Injection, USP label from Glenmark Pharmaceuticals Inc., USA, for intravenous use. The vial contains 25 single-dose 50 mL vials with concentrations of 150 mM P/50 mL (3 mM P/mL) and 200 mEq Na+/50 mL (4 mEq Na+/mL). The label cautions that the solution must be diluted before use and unused portions discarded.*

FDA Label Image

Sodium-phosphates-carton-5ml (Sodium Phosphates Carton 5ml)

Sodium Phosphates Injection, USP label displaying a 25-count package of 5 mL single-dose vials. The label shows concentrations of 15 mM phosphorus per 5 mL (3 mM P/mL) and 20 mEq sodium per 5 mL (4 mEq Na/mL). It includes caution that the product must be diluted and is for intravenous use. The labeler is Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Sodium-phosphates-container-15ml (Sodium Phosphates Container 15ml)

Sodium Phosphates Injection USP in a 15 mL single-dose vial. The label shows strengths of 45 mM phosphorus per 15 mL (3 mM/mL) and 60 mEq sodium per 15 mL (4 mEq/mL). It states the product is sterile, nonpyrogenic, and contains 276 mg sodium phosphate monobasic monohydrate per mL, equivalent to 268 mg sodium phosphate anhydrous per mL. The vial is for intravenous use only and must be diluted before administration. Distributed by Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Sodium-phosphates-container-50ml (Sodium Phosphates Container 50ml)

Sodium Phosphates Injection, USP label for intravenous use by Glenmark Pharmaceuticals Inc., USA. The label shows the strength as 150 mM P/50 mL (3 mM P/mL) and 200 mEq Na+/50 mL (4 mEq Na+/mL). It is a 50 mL single-dose vial with a caution that the product must be diluted before use. The label includes NDC 68462-730-50 and storage instructions.*

FDA Label Image

Sodium-phosphates-container-5ml (Sodium Phosphates Container 5ml)

Label for Sodium Phosphates Injection, USP, 15 mM P/5 mL (3 mM P/mL) and 20 mEq Na+/5 mL (4 mEq Na+/mL), in a 5 mL single-dose vial. The label includes a red caution that the product must be diluted and is for intravenous use. It is sterile and nonpyrogenic, with detailed ingredient information and storage instructions. The label shows the manufacturer as Glenmark Pharmaceuticals Inc., USA, and notes it is a product of India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.